Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
1,213
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

miRNA-144 targeting DNAJC3-AS1 reverses the resistance of the breast cancer cell line Michigan Cancer Foundation-7 to doxorubicin

Ruiping RenChemoradiotherapy Center of Oncology, The Affiliated People’s Hospital of Ningbo University, Zhejiang, Ningbo, 315000, RPChinaCorrespondence[email protected]
View further author information
,
Zuguo YuanChemoradiotherapy Center of Oncology, The Affiliated People’s Hospital of Ningbo University, Zhejiang, Ningbo, 315000, RPChinaView further author information
&
Zhengyang XuChemoradiotherapy Center of Oncology, The Affiliated People’s Hospital of Ningbo University, Zhejiang, Ningbo, 315000, RPChinaView further author information
Pages 9885-9892 | Received 17 Sep 2021, Accepted 22 Oct 2021, Published online: 11 Dec 2021

References

  • Jemal A, Siegel R, Ward E, et al. Cancer statistics. Ca Cancer J Clin. 2009;59(4):225-249.
  • Sharifi S, Barar J, Hejazi MS, et al. Doxorubicin changes Bax/Bcl-xL ratio, caspase-8 and 9 in breast cancer cells. Adv Pharm Bull. 2015;5(3):351.
  • Sun Q, Liu T, Yuan Y, et al. MiR‐200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. Int J Cancer. 2015;136(5):1003–1012.
  • Buyuklu M, Kandemir FM, Ozkaraca M, et al. Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis. Eur Rev Med Pharmacol Sci. 2014;18(4):461–470.
  • Eskelinen E-L, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta-Mol Cell Res. 2009;1793(4):664–673.
  • Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest. 2005;115(10):2679–2688.
  • Selvakumaran M, Amaravadi RK, Vasilevskaya IA, et al. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res. 2013;19(11):2995–3007.
  • Shi -T-T, Yu -X-X, Yan L-J, et al. Research progress of hydroxychloroquine and autophagy inhibitors on cancer. Cancer Chemother Pharmacol. 2017;79(2):287–294.
  • Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4(10):e838–e838.
  • Comincini S, Allavena G, Palumbo S, et al. microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. Cancer Biol Ther. 2013;14(7):574–586.
  • Wang P, Zhang J, Zhang L, et al. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology. 2013;145(5):1133–1143.
  • Yin Z, Li Y, Han X, et al. Genome-wide profiling of miRNAs and other small non-coding RNAs in the verticillium dahliae–inoculated cotton roots. PLoS One. 2012;7(4):e35765.
  • Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4):271–282.
  • Zha W, Cao L, Shen Y, et al. Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PLoS One. 2013;8(9):e74175.
  • Matsushita R, Seki N, Chiyomaru T, et al. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer. Br J Cancer. 2015;113(2):282–289.
  • Li Z, Zhao X, Zhou Y, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med. 2015;13(1):84.
  • Wang Y, Chen W, Yang C, et al. Long non-coding RNA UCA1a (CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol. 2012;41(1):276–284.
  • Wang Y, Zhang L, Zheng X, et al. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Cancer Lett. 2016;382(2):137–146.
  • Liang R, Liu Z, Chen Z, et al. Long noncoding RNA DNAJC3‐AS1 promotes osteosarcoma progression via its sense‐cognate gene DNAJC3. Cancer Med. 2019;8(2):761–772.
  • Zheng T, Wang J, Chen X, et al. Role of microRNA in anticancer drug resistance. Int J Cancer. 2010;126(1):2–10.
  • Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet. 2008;9(11):831–842.
  • Yin Y, Liu H, Xu J, et al. miR‑144‑3p regulates the resistance of lung cancer to cisplatin by targeting Nrf2. Oncol Rep. 2018;40(6):3479–3488.
  • Gupta N, Kumar R, Seth T, et al. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling. RNA Biol. 2020;17(1):98–111.
  • Jiang L, Meng W, Yu G, et al. MicroRNA‑144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p‑ERK/c‑Myc/MMP‑2 pathway. Oncol Lett. 2019;18(2):2034–2042.
  • Baird WM, Boutwell RK. Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. Cancer Res. 1971;31(8):1074–1079.
  • Shabani N, Sheikholeslami S, Paryan M, et al. An investigation on the expression of miRNAs including miR‐144 and miR‐34a in plasma samples of RET‐positive and RET‐negative medullar thyroid carcinoma patients. J Cell Physiol. 2020;235(2):1366–1373.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.